ArticleDermatology and therapy2026
Gestational Diabetes Mellitus Increases the Risk of Atopic Dermatitis in Children: A National Retrospective Study with Analysis by Treatment Modality.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAtopic dermatitis (AD) is a common childhood inflammatory disease influenced by genetic and environmental factors. Maternal metabolic conditions, including gestational diabetes mellitus (GDM), may affect offspring risk, but large population-based studies are limited. We aimed to examine the association between maternal GDM and offspring AD, and whether risk varies by maternal diabetes treatment type.
methodsWe conducted a retrospective cohort study of 326,611 mother-child dyads from Clalit Health Services, Israel, between 2010 and 2023. GDM was classified as diet-controlled (A1) or pharmacologically treated (A2). Offspring AD was identified using ICD-10 codes. Multivariable logistic regression estimated adjusted odds ratios (aORs), controlling for maternal age, allergic history, smoking, gestational age, infant sex, and follow-up duration.
resultsOf 16,008 (4.9%) mothers with GDM, offspring AD prevalence was higher than in non-GDM offspring (28% vs. 26%, p < 0.001). Maternal GDM was independently associated with increased offspring AD risk (aOR 1.07, 95% CI 1.03-1.11, p < 0.001). Additional independent predictors included maternal allergic rhinitis, asthma, smoking, male sex, and shorter gestational age.
conclusionMaternal GDM is associated with an increased risk of AD in offspring, independent of maternal allergic and perinatal factors, though causality cannot be inferred because of the retrospective study design. These findings may suggest a role of maternal metabolic health in early-life immune and skin barrier development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.